Merck , known as MSD outside of the United States and Canada, today announced positive topline results from the Phase 2 CADENCE study evaluating WINREVAIRtm (sotatercept-csrk) in adults for the ...
An 80-year-old man suffering from both a stroke and an acute myocardial infarction was saved within minutes thanks to FV ...
Background Percutaneous ventricular assist devices (pVAD) have been increasingly used to support haemodynamics during ...
Late-breaking results from clinical trials, debates about lifestyle choices and cardiovascular risk, and improving clinical care with generative AI are among the topics being presented by UC San ...
Infectious meningoencephalitis, characterized by inflammation of both the brain and adjacent meninges, is caused by a variety ...
Panelists discuss how ARNIs like sacubitril-valsartan provide superior outcomes compared with ACE inhibitors in HFrEF (20% reduction in cardiovascular events, 16% mortality reduction), with broad FDA ...
Medera is a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases by developing a range of next-generation therapeutics. Medera operates via ...
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that new sotagliflozin clinical data was presented at the AHA Annual Scientific Sessions 2025.
Sweden’s Saab 21 pushed design boundaries with a rear propeller and early ejection seat. Using the flawed Daimler-Benz DB 605 engine, engineers made over 1,000 modifications before flight. Test ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback